QIAGEN Partners with U.K. to Build a World-Leading Precision Medicine Campus
Manchester, England, & HILDEN, Germany - QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced their strategic partnership with Health Innovation Manchester to build a precision medicine campus in Manchester, U.K. This joint effort brings together the region's entire public, academic and clinical resources to develop a world-leading genomic campus for innovation, life sciences, translational science and molecular diagnostics.
“This is a hugely important step change for Greater Manchester's already strong life sciences sector. The new health innovation campus, with QIAGEN at its heart, will support the continued growth of businesses which are driving the future shape of medicine and health care, and cement our position as a world-leader in precision medicine,” said Rowena Burns, Chair of Health Innovation Manchester and Manchester Science Partnerships. “This is precisely what Health Innovation Manchester was set up to do, and combined with our devolved health and social care system, places us in an incredibly strong position to address the health challenges of the population.”
“These partnerships leverage QIAGEN’s rich expertise in Manchester to accelerate innovation as a basis for the development of valuable molecular tests. This is a true win-win situation, bringing together QIAGEN, the global leader in Sample to Insight solutions, with important intellectual assets in the U.K. to accelerate molecular biomarker research and subsequent development of new and promising diagnostic assays,” said Peer M. Schatz, Chief Executive Officer of QIAGEN. “We expect this collaborative initiative to serve as an innovation incubator to support translating genomic biomarkers into clinical use and ultimately to yield benefits for our customers and patients everywhere who need advanced diagnostic insights.”
Biotechnology To Improve Food Security
By Michael Hedges, VP and CIO, Medtronic
By Susan Doniz, Global CIO, Aimia
By Scott Welty, VP-Retail Strategy, JDA Software
By Deborah Gash, VP & CIO, Saint Luke’s Health System
By Bill Krivoshik, SVP & CIO, Time Warner Inc.
By Alberto Ruocco, CIO, American Electric Power
By Lisa Feldner, VC for Institutional Research & IT, North...
By Jim Kaskade, VP and GM, Big Data & Analytics, CSC
By Tom West, M.B.A., CIO, Nova Southeastern University
By Laura Jackson, Sr. Manager-Risk Management, ABS Consulting
By Bob Fecteau, CIO, SAIC
By Edward Grassia, CIO, Washoe County School District
By Henry Bailey, Global VP, Utilities IBU, SAP
By Elizabeth Hackenson, CIO & SVP of Global Business...
By Rosello, SVP & CIOO, Alliance Data Card Services
By Joseph Santamaria, CIO, PSEG [NYSE: PEG]
By Bill Schimikowski, VP, Customer Experience, Fidelity...
By Chad Lindbloom, CIO, C.H. Robinson
By Denise Zabawski, CIO, Nationwide Children's Hospital
By Charles Koontz, President & CEO, GE Healthcare IT & Chief...